Literature DB >> 22453651

Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters.

Pascal de Groote1, Marie Fertin, Céline Goéminne, Grégory Petyt, Sandrine Peyrot, Claude Foucher-Hossein, Frédéric Mouquet, Christophe Bauters, Nicolas Lamblin.   

Abstract

AIMS: Previous studies have demonstrated that the radionuclide right ventricular (RV) ejection fraction (RVEF), tricuspid annular plane systolic excursion (TAPSE), and tissue Doppler peak systolic tricuspid annular velocity (STr) were independent predictors of cardiac survival in stable patients with left ventricular systolic dysfunction (LVSD). No study has compared the prognostic value of these three RV parameters. The aim of this study was to compare the prognostic value of RVEF, TAPSE, and STr in a large group of patients with LVSD. METHODS AND
RESULTS: We analysed 527 consecutive patients who underwent an extensive prognostic evaluation (clinical data, biological data, radionuclide angiography, echoDopplercardiography, cardiopulmonary exercise test). Tricuspid annular plane systolic excursion and STr were weakly correlated with RVEF (r = 0.20). During a follow-up period of 1268 days (802-1830), there were 121 cardiovascular deaths. Best cut-off values were 37%, 9.7 cm/s, and 18.5 mm for RVEF, STr, and TAPSE, respectively. Right ventricular ejection fraction was a powerful independent predictor of cardiac survival [relative risk (RR): 2.05 (1.29-3.26), P = 0.002]. Peak systolic tricuspid annular velocity added a modest prognostic information [RR: 1.56 (1.02-2.39), P = 0.04]. However, the combination of STr with RVEF was the most powerful predictor of cardiovascular death. Tricuspid annular plane systolic excursion was not an independent predictor of cardiac survival.
CONCLUSIONS: Right ventricular systolic function remains a powerful independent predictor of the clinical outcome. Even in the context of a complete echocardiographic assessment, radionuclide RVEF continues to be the most powerful RV systolic parameter for cardiac survival prediction. However, the determination of STr, in addition to RVEF, could improve risk stratification.

Entities:  

Mesh:

Year:  2012        PMID: 22453651     DOI: 10.1093/eurheartj/ehs080

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Assessment and treatment of right ventricular failure.

Authors:  Marc A Simon
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

2.  Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction.

Authors:  Tomasz Kukulski; Lilin She; Normand Racine; Sinisa Gradinac; Julio A Panza; Eric J Velazquez; Kwan Chan; Mark C Petrie; Kerry L Lee; Patricia A Pellikka; Alexander Romanov; Jolanta Biernat; Jean L Rouleau; Carmen Batlle; Jan Rogowski; Paolo Ferrazzi; Marian Zembala; Jae K Oh
Journal:  J Thorac Cardiovasc Surg       Date:  2014-10-05       Impact factor: 5.209

3.  Predictors of right ventricular function improvement with sacubitril/valsartan in a real-life population of patients with chronic heart failure.

Authors:  Michele Correale; Pietro Mazzeo; Michele Magnesa; Martino Fortunato; Lucia Tricarico; Alessandra Leopizzi; Adriana Mallardi; Raffaele Mennella; Salvatore Tucci; Natale Daniele Brunetti
Journal:  Clin Physiol Funct Imaging       Date:  2021-09-28       Impact factor: 2.121

Review 4.  A right ventricular state of mind in the progression of heart failure with reduced ejection fraction: implications for left ventricular assist device therapy.

Authors:  Ersilia M DeFilippis; Marco Guazzi; Paolo C Colombo; Melana Yuzefpolskaya
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

5.  Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failure.

Authors:  Gilles Lemesle; Fleur Maury; Olivia Beseme; Lionel Ovart; Philippe Amouyel; Nicolas Lamblin; Pascal de Groote; Christophe Bauters; Florence Pinet
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

6.  Quantifying longitudinal right ventricular dysfunction in patients with old myocardial infarction by using speckle-tracking strain echocardiography.

Authors:  Katsuhisa Konishi; Kaoru Dohi; Muneyoshi Tanimura; Yuichi Sato; Kiyotaka Watanabe; Emiyo Sugiura; Naoto Kumagai; Shiro Nakamori; Hiroshi Nakajima; Tomomi Yamada; Katsuya Onishi; Mashio Nakamura; Tsutomu Nobori; Masaaki Ito
Journal:  Cardiovasc Ultrasound       Date:  2013-06-27       Impact factor: 2.062

7.  Risk stratification of patients with chronic heart failure using cardiac iodine-123 metaiodobenzylguanidine imaging: incremental prognostic value over right ventricular ejection fraction.

Authors:  Shunsuke Tamaki; Takahisa Yamada; Takashi Morita; Yoshio Furukawa; Yusuke Iwasaki; Masato Kawasaki; Atsushi Kikuchi; Takumi Kondo; Tsutomu Kawai; Satoshi Takahashi; Masashi Ishimi; Hideyuki Hakui; Tatsuhisa Ozaki; Yoshihiro Sato; Masahiro Seo; Yasushi Sakata; Masatake Fukunami
Journal:  ESC Heart Fail       Date:  2015-08-17

8.  Right ventricular dysfunction assessed by cardiovascular magnetic resonance is associated with poor outcome in patients undergoing transcatheter mitral valve repair.

Authors:  Maximilian Spieker; Jonathan Marpert; Shazia Afzal; Athanasios Karathanos; Daniel Scheiber; Florian Bönner; Patrick Horn; Malte Kelm; Ralf Westenfeld
Journal:  PLoS One       Date:  2021-01-29       Impact factor: 3.240

Review 9.  Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues.

Authors:  Emmanuelle Berthelot; Fabrice Bauer; Jean-Christophe Eicher; Erwan Flécher; Barnabas Gellen; Julien Guihaire; Damien Guijarro; Gérald Roul; Muriel Salvat; Christophe Tribouilloy; Florian Zores; Nicolas Lamblin; Pascal de Groote; Thibaud Damy
Journal:  ESC Heart Fail       Date:  2018-07-20

10.  Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry.

Authors:  Michele Correale; Adriana Mallardi; Pietro Mazzeo; Lucia Tricarico; Claudia Diella; Valentina Romano; Armando Ferraretti; Alessandra Leopizzi; Giuseppina Merolla; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Int J Cardiol Heart Vasc       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.